Dallas, TX, United States of America

Travis Michael Whitfill

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 1.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • New Haven, CT (US) (2020)
  • Dallas, TX (US) (2021 - 2024)

Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations by Travis Michael Whitfill

Introduction

Travis Michael Whitfill is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of biotechnology, particularly in the treatment of inflammatory skin diseases. With a total of 6 patents to his name, Whitfill's work is at the forefront of innovative therapeutic solutions.

Latest Patents

Among his latest patents, one titled "Methods and compositions for treating inflammatory skin disease with recombinant microorganisms" provides isolated plasmids, recombinant microorganisms, kits, and methods for the treatment of inflammatory skin disease. Another significant invention, "Therapeutic treatment of skin disease with recombinant commensal skin microorganisms," relates to methods for treating or preventing abnormal skin conditions in humans. This invention involves administering a cell culture composition comprising a living culture of bacteria that includes at least one engineered strain producing a recombinant polypeptide for therapeutic treatment. Additionally, it encompasses pharmaceutical compositions containing engineered microorganisms that express non-vaccinogenic pharmacologically active recombinant therapeutic polypeptides to treat or prevent abnormal skin conditions.

Career Highlights

Travis Michael Whitfill is currently associated with Azitra Inc., a company dedicated to advancing skin health through innovative biotechnology. His work at Azitra Inc. reflects his commitment to developing effective treatments for skin diseases.

Collaborations

Some of his notable coworkers include Azim Momin Munivar and Ming-De Deng, who contribute to the collaborative efforts at Azitra Inc. to push the boundaries of skin disease treatment.

Conclusion

Travis Michael Whitfill's innovative work in biotechnology, particularly in the treatment of inflammatory skin diseases, showcases his dedication to improving health outcomes through scientific advancements. His contributions are paving the way for new therapeutic options in dermatology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…